Table 3 Descriptions of mHealth Lakefolk Actively Keeping Engaged (mLAKE) trial primary (1°) and secondary (2°) study outcomes^a

1°

HIV care coverage^b

Proportion

# linked to HIV care

# HIV-positive

1°

ART coverage^b

Proportion

# on antiretroviral therapy (ART)

# HIV-positive

1°

MC coverage^b

Proportion

# non-Muslim men circumcised

All non-Muslim men aged 15–49 years

1°

HIV population viremia prevalence (PVP)

Proportion

HIV+ c VL > 400

All study participants

2°

HIV incidence

Rate

# new HIV infections

HIV-negative person-years

2°

HTS coverage

Proportion

# ever tested and received HIV results

All study participants

2°

ART treatment failure^c

Proportion

Composite: virologic failure or Mortality or lost to follow-up or stopped ART

# initiated on ART

2°

Consistent condom use^b

Proportion

# using condoms consistently past 12 months

# sexually active